We are live on ! Find out more
CNBT

Cornerstone National Bank & Trust Portfolio holdings

AUM $296M
1-Year Est. Return 12.13%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+12.13%
3 Year Est. Return
+33.95%
5 Year Est. Return
+27.34%
10 Year Est. Return
AUM
$296M
AUM Growth
+$24.4M
Cap. Flow
+$10.7M
Cap. Flow %
3.62%
Top 10 Hldgs %
51.39%
Holding
224
New
15
Increased
25
Reduced
66
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
201
Marsh
MRSH
$90.5B
$3.62K ﹤0.01%
21
-354
-94% -$59.2K
PYPL icon
202
PayPal
PYPL
$48.9B
$3.53K ﹤0.01%
80
VTRS icon
203
Viatris
VTRS
$20.4B
$3.01K ﹤0.01%
186
EMR icon
204
Emerson Electric
EMR
$83.9B
$2.09K ﹤0.01%
15
T icon
205
AT&T
T
$159B
$2.05K ﹤0.01%
100
SPH icon
206
Suburban Propane Partners
SPH
$1.24B
$1.88K ﹤0.01%
108
BHF icon
207
Brighthouse Financial
BHF
$3.56B
$1.73K ﹤0.01%
27
FSK icon
208
FS KKR Capital
FSK
$2.96B
$511 ﹤0.01%
+48
New +$516
CHTR icon
209
Charter Communications
CHTR
$17.3B
$420 ﹤0.01%
3
SOLS
210
Solstice Advanced Materials
SOLS
$9.56B
$415 ﹤0.01%
5
WBD icon
211
Warner Bros
WBD
$65.9B
$295 ﹤0.01%
11
-472
-98% -$12.8K
PTLO icon
212
Portillo's
PTLO
$331M
$230 ﹤0.01%
46
AAL icon
213
American Airlines Group
AAL
$10.1B
-1,000
Closed -$11.1K
ADBE icon
214
Adobe
ADBE
$99.5B
-25
Closed -$6.03K
FOXA icon
215
Fox Class A
FOXA
$24.5B
-2
Closed -$117
HON icon
216
Honeywell
HON
$77B
-23
Closed -$5.25K
LLY icon
217
Eli Lilly
LLY
$1.02T
-166
Closed -$158K
NWSA icon
218
News Corp Class A
NWSA
$14.9B
-1
Closed -$25
TAK icon
219
Takeda Pharmaceutical
TAK
$54.6B
-956
Closed -$17.9K
UNH icon
220
UnitedHealth
UNH
$376B
-400
Closed -$110K

Similar funds

Cornerstone National Bank & Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Cornerstone National Bank & Trust held 224 positions worth $296M, up 9% from $271M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cornerstone National Bank & Trust deployed $10.7M of net new capital in Q2 2026, opening 15 new positions and adding to 25 existing holdings. Its largest new stake was Gilead Sciences: 1,400 shares worth $176K.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 7.4% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was FlexShares Credit-Scored US Corporate Bond Index Fund, an estimated $6.07M trimmed.

  • Cornerstone National Bank & Trust's largest Q2 2026 buy was Gilead Sciences: 1,400 shares worth $176K.
  • Cornerstone National Bank & Trust added most to iShares Core US Aggregate Bond ETF in Q2 2026, an estimated $8.78M increase.
  • Cornerstone National Bank & Trust's biggest Q2 2026 reduction was FlexShares Credit-Scored US Corporate Bond Index Fund, cutting an estimated $6.07M.
  • Cornerstone National Bank & Trust fully exited Eli Lilly in Q2 2026, selling an estimated $158K.
  • Cornerstone National Bank & Trust's ten largest holdings make up 51% of its $296M portfolio in Q2 2026.
  • Cornerstone National Bank & Trust opened 15 new positions and closed 8 in Q2 2026.
  • Cornerstone National Bank & Trust's portfolio value rose 9% quarter-over-quarter to $296M.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.